Evidence map›Paper›PMID 29567982›Full record

ArticleBritish journal of cancer2018

The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.

Katrina F Brown, Harriet Rumgay, Casey Dunlop, Margaret Ryan, Frances Quartly, Alison Cox, Andrew Deas, Lucy Elliss-Brookes, Anna Gavin, Luke Hounsome and 5 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 266 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
266citing papers in PubMed, 15 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04697264 completednot on this mapstarted 2021, after this paper: background citation

Adipocytokines and Their Relationship to Obesity and Endometrial Cancer

TypeobservationalSponsorUniversity of SurreyRan2021 to 2023Enrolled100ConditionsEndometrial Cancer, ObesityArmsBlood and tissue sample collection from patients
NCT06304922 unknown statusnot on this mapstarted 2024, after this paper: background citation

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

TypeobservationalSponsorAssiut UniversityRan2024 to 2026Enrolled45ConditionsOvarian CancerArmsAssess the response to platinum-based chemotherapy in correlation to BRCA status in neoadjuvant and recurrent ovarian cancer
3 · Its place in the literature

Who cites it

266 citing papers in PubMed, 15 syntheses or guidelines pooled it, 543 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Exposure to Tobacco-Specific Nitrosamines Among People Who Vape, Smoke, or do Neither: A Systematic Review and Meta-Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Preventative therapy for breast cancer: a clinical experience.Breast cancer research and treatment · 2023
    Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

206 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Katrina F BrownPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK. katrina.brown@cancer.org.uk.
Harriet RumgayPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Casey DunlopPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Margaret RyanPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Frances QuartlyPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Alison CoxPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Andrew DeasNHS National Services Scotland, Information Services Division, Meridian Court, 5 Cadogan Street, Glasgow, G2 6QE, Scotland.
Lucy Elliss-BrookesNational Cancer Registration and Analysis Service, Public Health England, 2nd Floor, Skipton House, 80 London Road, London, SE1 6LH, UK.ORCID http://orcid.org/0000-0003-1159-6607
Anna GavinNorthern Ireland Cancer Registry, Centre for Public Health, Queens University Belfast, Mulhouse Building, Grosvenor Road, Belfast, BT12 6DP, Ireland.
Luke HounsomeNational Cancer Registration and Analysis Service, Public Health England, 2nd Floor, Skipton House, 80 London Road, London, SE1 6LH, UK.ORCID http://orcid.org/0000-0001-5231-1394
Dyfed HuwsWelsh Cancer Intelligence and Surveillance Unit, Floor 5, Public Health Wales, Number 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ, Wales.
Nick Ormiston-SmithPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Jon SheltonPolicy and Information Directorate, Cancer Research UK, The Angel Building, 407 St John Street, London, EC1V 4AD, UK.
Ceri WhiteWelsh Cancer Intelligence and Surveillance Unit, Floor 5, Public Health Wales, Number 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ, Wales.
D Max ParkinCentre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Cancer Research UK · GBPublic Health England · GBPublic Health Wales · GBNational Health Service Scotland · GBQueen Mary University of London · GB

Funding

Cancer Research UK
6 · The paper itself

Abstract

backgroundChanging population-level exposure to modifiable risk factors is a key driver of changing cancer incidence. Understanding these changes is therefore vital when prioritising risk-reduction policies, in order to have the biggest impact on reducing cancer incidence. UK figures on the number of risk factor-attributable cancers are updated here to reflect changing behaviour as assessed in representative national surveys, and new epidemiological evidence. Figures are also presented by UK constituent country because prevalence of risk factor exposure varies between them.

methodsPopulation attributable fractions (PAFs) were calculated for combinations of risk factor and cancer type with sufficient/convincing evidence of a causal association. Relative risks (RRs) were drawn from meta-analyses of cohort studies where possible. Prevalence of exposure to risk factors was obtained from nationally representative population surveys. Cancer incidence data for 2015 were sourced from national data releases and, where needed, personal communications. PAF calculations were stratified by age, sex and risk factor exposure level and then combined to create summary PAFs by cancer type, sex and country.

resultsNearly four in ten (37.7%) cancer cases in 2015 in the UK were attributable to known risk factors. The proportion was around two percentage points higher in UK males (38.6%) than in UK females (36.8%). Comparing UK countries, the attributable proportion was highest in Scotland (41.5% for persons) and lowest in England (37.3% for persons). Tobacco smoking contributed by far the largest proportion of attributable cancer cases, followed by overweight/obesity, accounting for 15.1% and 6.3%, respectively, of all cases in the UK in 2015. For 10 cancer types, including two of the five most common cancer types in the UK (lung cancer and melanoma skin cancer), more than 70% of UK cancer cases were attributable to known risk factors.

conclusionTobacco and overweight/obesity remain the top contributors of attributable cancer cases. Tobacco smoking has the highest PAF because it greatly increases cancer risk and has a large number of cancer types associated with it. Overweight/obesity has the second-highest PAF because it affects a high proportion of the UK population and is also linked with many cancer types. Public health policy may seek to mitigate the level of harm associated with exposure or reduce exposure levels-both approaches may effectively impact cancer incidence. Differences in PAFs between countries and sexes are primarily due to varying prevalence of exposure to risk factors and varying proportions of specific cancer types. This variation in turn is affected by socio-demographic differences which drive differences in exposure to theoretically avoidable 'lifestyle' factors. PAFs at UK country level have not been available previously and they should be used by policymakers in devolved nations. PAFs are estimates based on the best available data, limitations in those data would generally bias toward underestimation of PAFs. Regular collection of risk factor exposure prevalence data which corresponds with epidemiological evidence is vital for analyses like this and should remain a priority for the UK Government and devolved Administrations.

Indexed as

Effect Modifier, EpidemiologicEnglandEnvironmental ExposureExerciseFemaleHealth BehaviorHumansIncidenceLife StyleMaleNeoplasmsNorthern IrelandObesityOccupationsOverweightPrevalence

Identifiers

PMID29567982
PMCPMC5931106
OpenAlexW2792039871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.